94 related articles for article (PubMed ID: 25723494)
1. Differences in the direction of change of cerebral function parameters are evident over three years in HIV-infected individuals electively commencing initial cART.
Winston A; Puls R; Kerr SJ; Duncombe C; Li P; Gill JM; Ramautarsing R; Taylor-Robinson SD; Emery S; Cooper DA;
PLoS One; 2015; 10(2):e0118608. PubMed ID: 25723494
[TBL] [Abstract][Full Text] [Related]
2. Does choice of combination antiretroviral therapy (cART) alter changes in cerebral function testing after 48 weeks in treatment-naive, HIV-1-infected individuals commencing cART? A randomized, controlled study.
Winston A; Duncombe C; Li PC; Gill JM; Kerr SJ; Puls R; Petoumenos K; Taylor-Robinson SD; Emery S; Cooper DA;
Clin Infect Dis; 2010 Mar; 50(6):920-9. PubMed ID: 20146627
[TBL] [Abstract][Full Text] [Related]
3. Two patterns of cerebral metabolite abnormalities are detected on proton magnetic resonance spectroscopy in HIV-infected subjects commencing antiretroviral therapy.
Winston A; Duncombe C; Li PC; Gill JM; Kerr SJ; Puls RL; Taylor-Robinson SD; Emery S; Cooper DA;
Neuroradiology; 2012 Dec; 54(12):1331-9. PubMed ID: 22772471
[TBL] [Abstract][Full Text] [Related]
4. Differences in the variability of cerebral proton magnetic resonance spectroscopy (1H-MRS) measurements within three HIV-infected cohorts.
Vigneswaran S; Rojas JH; Garvey L; Taylor-Robinson S; Winston A
Neuroradiol J; 2015 Dec; 28(6):545-54. PubMed ID: 26493269
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of metabolic changes within the normal appearing gray and white matters in neurologically asymptomatic HIV-1-positive and HCV-positive patients: magnetic resonance spectroscopy and immunologic correlation.
Bladowska J; Zimny A; Kołtowska A; Szewczyk P; Knysz B; Gąsiorowski J; Furdal M; Sąsiadek MJ
Eur J Radiol; 2013 Apr; 82(4):686-92. PubMed ID: 23246331
[TBL] [Abstract][Full Text] [Related]
6. Neurometabolic Remodeling in Chronic Hiv Infection: a Five-Year Follow-up Multi-Voxel Mrs Study.
Boban J; Thurnher MM; Brkic S; Lendak D; Bugarski Ignjatovic V; Todorovic A; Kozic D
Sci Rep; 2019 Dec; 9(1):19799. PubMed ID: 31875001
[TBL] [Abstract][Full Text] [Related]
7. A comparison of two post-processing analysis methods to quantify cerebral metabolites measured via proton magnetic resonance spectroscopy in HIV disease.
Scott J; Underwood J; Garvey LJ; Mora-Peris B; Winston A
Br J Radiol; 2016; 89(1060):20150979. PubMed ID: 26954329
[TBL] [Abstract][Full Text] [Related]
8. Dynamics of cognitive change in HIV-infected individuals commencing three different initial antiretroviral regimens: a randomized, controlled study.
Winston A; Puls R; Kerr SJ; Duncombe C; Li PC; Gill JM; Taylor-Robinson SD; Emery S; Cooper DA;
HIV Med; 2012 Apr; 13(4):245-51. PubMed ID: 22151608
[TBL] [Abstract][Full Text] [Related]
9. A prospective longitudinal in vivo 1H MR spectroscopy study of the SIV/macaque model of neuroAIDS.
Fuller RA; Westmoreland SV; Ratai E; Greco JB; Kim JP; Lentz MR; He J; Sehgal PK; Masliah E; Halpern E; Lackner AA; González RG
BMC Neurosci; 2004 Mar; 5():10. PubMed ID: 15070430
[TBL] [Abstract][Full Text] [Related]
10. Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease.
Wang Z; Zhao C; Yu L; Zhou W; Li K
Acta Radiol; 2009 Apr; 50(3):312-9. PubMed ID: 19235582
[TBL] [Abstract][Full Text] [Related]
11. Early Introduction of cART Reverses Brain Aging Pattern in Well-Controlled HIV Infection: A Comparative MR Spectroscopy Study.
Boban JM; Kozic DB; Brkic SV; Lendak DF; Thurnher MM
Front Aging Neurosci; 2018; 10():329. PubMed ID: 30405398
[No Abstract] [Full Text] [Related]
12. Combination antiretroviral therapy improves cognitive performance and functional connectivity in treatment-naïve HIV-infected individuals.
Zhuang Y; Qiu X; Wang L; Ma Q; Mapstone M; Luque A; Weber M; Tivarus M; Miller E; Arduino RC; Zhong J; Schifitto G
J Neurovirol; 2017 Oct; 23(5):704-712. PubMed ID: 28791662
[TBL] [Abstract][Full Text] [Related]
13. A multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to age.
Chang L; Lee PL; Yiannoutsos CT; Ernst T; Marra CM; Richards T; Kolson D; Schifitto G; Jarvik JG; Miller EN; Lenkinski R; Gonzalez G; Navia BA;
Neuroimage; 2004 Dec; 23(4):1336-47. PubMed ID: 15589098
[TBL] [Abstract][Full Text] [Related]
14. Two-dimensional 1H MR spectroscopy of the brain in human immunodeficiency virus (HIV)-infected children.
Banakar S; Thomas MA; Deveikis A; Watzl JQ; Hayes J; Keller MA
J Magn Reson Imaging; 2008 Apr; 27(4):710-7. PubMed ID: 18383256
[TBL] [Abstract][Full Text] [Related]
15. Neuronal-Glia Markers by Magnetic Resonance Spectroscopy in HIV Before and After Combination Antiretroviral Therapy.
Sailasuta N; Ananworanich J; Lerdlum S; Sithinamsuwan P; Fletcher JL; Tipsuk S; Pothisri M; Jadwattanakul T; Jirajariyavej S; Chalermchai T; Catella S; Busovaca E; Desai A; Paul R; Valcour V;
J Acquir Immune Defic Syndr; 2016 Jan; 71(1):24-30. PubMed ID: 26258565
[TBL] [Abstract][Full Text] [Related]
16. Using proton magnetic resonance spectroscopy to identify mild cognitive impairment.
Wang T; Xiao S; Li X; Ding B; Ling H; Chen K; Fang Y
Int Psychogeriatr; 2012 Jan; 24(1):19-27. PubMed ID: 21676281
[TBL] [Abstract][Full Text] [Related]
17. Acute HCV/HIV coinfection is associated with cognitive dysfunction and cerebral metabolite disturbance, but not increased microglial cell activation.
Garvey LJ; Pavese N; Ramlackhansingh A; Thomson E; Allsop JM; Politis M; Kulasegaram R; Main J; Brooks DJ; Taylor-Robinson SD; Winston A
PLoS One; 2012; 7(7):e38980. PubMed ID: 22808022
[TBL] [Abstract][Full Text] [Related]
18. Cerebral metabolites in HIV-infected children followed for 10 months with 1H-MRS.
Keller MA; Venkatraman TN; Thomas MA; Deveikis A; Lopresti C; Hayes J; Berman N; Walot I; Ernst T; Chang L
Neurology; 2006 Mar; 66(6):874-9. PubMed ID: 16567705
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.
Bladowska J; Zimny A; Knysz B; Małyszczak K; Kołtowska A; Szewczyk P; Gąsiorowski J; Furdal M; Sąsiadek MJ
J Hepatol; 2013 Oct; 59(4):651-7. PubMed ID: 23680314
[TBL] [Abstract][Full Text] [Related]
20. Proxies of cognitive reserve and their effects on neuropsychological performance in patients with mild cognitive impairment.
Liu Y; Cai ZL; Xue S; Zhou X; Wu F
J Clin Neurosci; 2013 Apr; 20(4):548-53. PubMed ID: 23406880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
